Final answer:
When communicating information about valproate (Depakote) to a patient, it is important to mention the need for baseline Hgb A1C levels and regular follow-ups, as well as the importance of notifying the physician about signs of new or worsening depression.
Step-by-step explanation:
When communicating information concerning valproate (Depakote) to a patient, two correct statements should be mentioned:
- Obtain baseline Hgb A1C with follow-up every 6 months
- Notify the physician if any signs of new or worsening depression are noted